Literature DB >> 8964746

Erythropoietin does not demonstrate circadian rhythm in healthy men.

D Roberts1, D J Smith.   

Abstract

The hormone erythropoietin (Epo) produced in the kidneys in response to hypoxia stimulates the production of red blood cells. We measured serum Epo levels in 26 healthy men over a 24-h period to determine whether Epo is secreted according to a circadian rhythm. Samples were collected every 2-4 h, and Epo was measured by using a radioimmunoassay (INCSTAR Epo-trac). To determine whether blood collection had any effect on Epo production, one-half of the subjects began the collection period in the morning and the other half in the evening. Exercise and the use of prostaglandin inhibitors were prohibited to eliminate fluctuations in Epo production in response to discrete stimuli. The daily Epo concentration for all subjects combined was 15.5 +/- 5.3 (SD) U/l. No significant circadian variation in serum Epo concentrations was observed in either group or when both groups were combined; however, a measure of individual variance was observed (mean deviation = 0.8 +/- 0.4 U/l).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964746     DOI: 10.1152/jappl.1996.80.3.847

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Determining an erythropoietin threshold is not sufficient for accelerating erythrocyte production by Julien V. Brugniaux, Aurélien Pichon.

Authors:  Gustave Savourey; Pietro E di Prampero
Journal:  Eur J Appl Physiol       Date:  2006-12-13       Impact factor: 3.078

2.  Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the "normobaric oxygen paradox".

Authors:  Tadej Debevec; Michail E Keramidas; Barbara Norman; Thomas Gustafsson; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

3.  Serum erythropoietin level and mortality in kidney transplant recipients.

Authors:  Miklos Z Molnar; Adam G Tabak; Ahsan Alam; Maria E Czira; Anna Rudas; Akos Ujszaszi; Gabriella Beko; Marta Novak; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 4.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 5.  Circadian sleep-wake rhythm disturbances in end-stage renal disease.

Authors:  Birgit C P Koch; J Elsbeth Nagtegaal; Gerard A Kerkhof; Piet M ter Wee
Journal:  Nat Rev Nephrol       Date:  2009-05-26       Impact factor: 28.314

6.  Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients.

Authors:  David Montero; Thomas Haider; Jens Barthelmes; Jens P Goetze; Silviya Cantatore; Carsten Lundby; Isabella Sudano; Frank Ruschitzka; Andreas J Flammer
Journal:  Physiol Rep       Date:  2019-03

7.  Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness.

Authors:  Francisco C Villafuerte; Noemí Corante; Cecilia Anza-Ramírez; Rómulo Figueroa-Mujíca; Gustavo Vizcardo-Galindo; Andy Mercado; José Luis Macarlupú; Fabiola León-Velarde
Journal:  J Appl Physiol (1985)       Date:  2016-04-28

8.  Hemoglobin and Erythropoietin After Commercial Saturation Diving.

Authors:  Fatima Z Kiboub; Costantino Balestra; Øyvind Loennechen; Ingrid Eftedal
Journal:  Front Physiol       Date:  2018-08-21       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.